Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Novo Nordisk's Tolerogenic DNA?
Tolerogenic DNA is a gene therapy commercialized by Novo Nordisk, with a leading Phase I program in Type 1 Diabetes...